Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Scandinavian Journal of Urology|November 28, 2012
Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: can nerve-sparing surgery increase the risk?Martin Andreas Røder, Frederik Birkebæk Thomsen, Ib Jarle Christensen, et al.
Metabolic Brain Disease|December 11, 2008
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammoniaLasse K Bak, Peter Iversen, Michael Sørensen, et al.
Ugeskrift for Laeger|May 20, 2011
[Cryotherapy of prostatic cancer]Peter Iversen, Per Bagi, Klaus Brasso, et al.
Scandinavian Journal of Urology|May 6, 2014
Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancerJoen Sveistrup, Anders Widmark, Per Fransson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2015
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 studyFrederik B Thomsen, Klaus Brasso, Ib J Christensen, et al.
Journal of Surgical Oncology|October 25, 2013
Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomyMartin Andreas Røder, Frederik Birkebæk Thomsen, Kasper Drimer Berg, et al.
Journal of Surgical Oncology|February 14, 2014
Non-apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrenceMartin Andreas Røder, Sandra Kawa, Thomas Scheike, et al.
Cancer Causes & Control : CCC|November 18, 2015
Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patientsThine Hvid, Birgitte Lindegaard, Kamilla Winding, et al.
Neuroimage|February 9, 2008
Normalization in PET group comparison studies--the importance of a valid reference regionPer Borghammer, Kristjana Yr Jonsdottir, Paul Cumming, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Scandinavian Journal of Urology|November 28, 2012
Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: can nerve-sparing surgery increase the risk?Martin Andreas Røder, Frederik Birkebæk Thomsen, Ib Jarle Christensen, et al.
Metabolic Brain Disease|December 11, 2008
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammoniaLasse K Bak, Peter Iversen, Michael Sørensen, et al.
Ugeskrift for Laeger|May 20, 2011
[Cryotherapy of prostatic cancer]Peter Iversen, Per Bagi, Klaus Brasso, et al.
Scandinavian Journal of Urology|May 6, 2014
Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancerJoen Sveistrup, Anders Widmark, Per Fransson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2015
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 studyFrederik B Thomsen, Klaus Brasso, Ib J Christensen, et al.
Journal of Surgical Oncology|October 25, 2013
Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomyMartin Andreas Røder, Frederik Birkebæk Thomsen, Kasper Drimer Berg, et al.
Journal of Surgical Oncology|February 14, 2014
Non-apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrenceMartin Andreas Røder, Sandra Kawa, Thomas Scheike, et al.
Cancer Causes & Control : CCC|November 18, 2015
Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patientsThine Hvid, Birgitte Lindegaard, Kamilla Winding, et al.
Neuroimage|February 9, 2008
Normalization in PET group comparison studies--the importance of a valid reference regionPer Borghammer, Kristjana Yr Jonsdottir, Paul Cumming, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.
Pageof 16